Phase II trial of neoadjuvant estramustine and etoposide plus radical prostatectomy for locally advanced prostate cancer

Author： Clark P.E. Peereboom D.M. Dreicer R. Levin H.S. Clark S.B. Klein E.A.

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.57, Iss.2, 2001-02, pp. : 281-285

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A phase II trial of oral estramustine and oral etoposide in hormone refractory prostate cancer

By Pienta K.J. Redman B.G. Bandekar R. Strawderman M. Cease K. Esper P.S. Naik H. Smith D.C.

Urology, Vol. 50, Iss. 3, 1997-09 ,pp. : 401-407

Elsevier

Access to resources Recommend Favorite

Phase I trial of weekly paclitaxel plus oral estramustine phosphate in patients with hormone-refractory prostate cancer

By Haas N. Roth B. Garay C. Yeslow G. Entmacher M. Weinstein A. Rogatko A. Babb J. Minnitti C. Flinker D. Gillon T. Hudes G.

Urology, Vol. 58, Iss. 1, 2001-07 ,pp. : 59-64

Elsevier

Access to resources Recommend Favorite

Phase II study of docetaxel and estramustine in metastatic androgen-independent prostate cancer

By Guimaraes T. Bento M.J. Pinho T. Guedes d.C.R. Pinto F.

European Urology Supplements, Vol. 1, Iss. 1, 2002-01 ,pp. : 159-159

Elsevier

Access to resources Recommend Favorite

Oral estramustine and oral etoposide for hormone-refractory prostate cancer

By Dimopoulos M.A. Panopoulos C. Bamia C. Deliveliotis C. Alivizatos G. Pantazopoulos D. Constantinidis C. Kostakopoulos A. Kastriotis I. Zervas A. Aravantinos G. Dimopoulos C.

Urology, Vol. 50, Iss. 5, 1997-11 ,pp. : 754-758

Elsevier

Access to resources Recommend Favorite

Effect of estramustine, etoposide, and taxol on prostate cancer cell growth in vitro and in vivo

By Pienta K.J. Naik H. Lehr J.E.

Urology, Vol. 48, Iss. 1, 1996-07 ,pp. : 164-170

Elsevier

Access to resources Recommend Favorite